Rising Obesity Prevalence and Weight Gain among Adults Starting Antiretroviral Therapy in the United States and Canada

AIDS Research and Human Retroviruses

Volumn 32, Issue 1, 2016, Pages 50-58

  Koethe, John R ^a   Jenkins, Cathy A ^a   Lau, Bryan ^b   Shepherd, Bryan E ^a   Justice, Amy C ^c,d   Tate, Janet P ^c,d   Buchacz, Kate ^e   Napravnik, Sonia ^f   Mayor, Angel M ^g   Horberg, Michael A ^h   Blashill, Aaron J ⁱ   Willig, Amanda ^j   Wester, C William ^a   Silverberg, Michael J ^k   Gill, John ^l   Thorne, Jennifer E ^b   Klein, Marina ^m   Eron, Joseph J ^f   Kitahata, Mari M ⁿ   Sterling, Timothy R ^a   Moore, Richard D ^b   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g SCHOOL OF MEDICINE   (Puerto Rico)

^h Mid Atlantic Permanente Research Institute   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k KAISER PERMANENTE   (United States)

^l Sheldon M Chumir Health Centre   (Canada)

^m MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; BLACK PERSON; BODY MASS; CANADA; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; UNDERWEIGHT; UNITED STATES; VIRUS LOAD; WEIGHT CHANGE; WEIGHT GAIN; YOUNG ADULT; COMPLICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; NUTRITION; PHYSIOLOGY; RISK FACTOR; VIROLOGY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CANADA; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PREVALENCE; RISK FACTORS; UNITED STATES; WEIGHT GAIN;

EID: 84954186194     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2015.0147     Document Type: Conference Paper

References (40)

1. The State of Obesity 2014: Robert Wood Johnson Foundation; 2014. Available at http://stateofobesity. org/files/ stateofobesity2014. pdf
2. Adult Obesity Prevalence in Canada and the United States: NCHS data brief, no. 56. National Center for Health Statistics, Hyattsville, MD, 2011
3. Statistics Canada: Measured adult body mass index (BMI) by age group and sex, household population age 18 and over excluding pregnant females, Canada (excluding territories). (CANSIM table 105-0507. ) Statistics Canada, Ottawa, 2009
4. Crum-Cianflone N, Roediger MP, Eberly L, et al. : Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One 2010;5:e10106
5. Amorosa V, Synnestvedt M, Gross R, et al. : A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005; 39:557-561
6. Tate T, Willig AL, Willig JH, et al. : HIV infection and obesity: Where did all the wasting go? Antivir Ther 2012; 17:1281-1289
7. Taylor BS, Liang Y, Garduno LS, et al. : High risk of obesity and weight gain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr 2014;65:e33-40
8. Kim DJ, Westfall AO, Chamot E, et al. : Multimorbidity patterns in HIV-infected patients: The role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr 2012;61:600-605
9. Mulligan K, Harris DR, Monte D, et al. : Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin Infect Dis 2010; 50:106-114
10. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, et al. : Role of obesity, metabolic variables, and diabetes in HIVassociated neurocognitive disorder. Neurology 2012;78: 485-492
11. Berrahmoune H, Herbeth B, Samara A, et al. : Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: The Stanislas study. Int J Obes (Lond) 2008;32:1279-1288
12. Fransson EI, Batty GD, Tabak AG, et al. : Association between change in body composition and change in inflammatory markers: An 11-year follow-up in the Whitehall II Study. J Clin Endocrinol Metab 2010;95:5370-5374
13. Alley DE and Chang VW: Metabolic syndrome and weight gain in adulthood. J Gerontol A Biol Sci Med Sci 2010;65: 111-117
14. Chan JM, Rimm EB, Colditz GA, et al. : Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-969
15. Gange SJ, Kitahata MM, Saag MS, et al. : Cohort profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007; 36:294-301
16. National Heart, Lung, and Blood Institute (NHLBI): The Evidence Report: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Department of Health and Human Services, National Heart, Lung, and Blood Institute, Bethesda, MD. NIH Publication No. 98-4083, 1998
17. Harrell FE: Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer-Verlag, New York, 2001
18. Johnson CL, Paulose-Ram R, Ogden CL, et al. : National Health and Nutrition Examination Survey: Analytic Guidelines, 1999-2010. Vital and Health Statistics Reports Series 2, 2013
19. Tedaldi EM, Brooks JT, Weidle PJ, et al. : Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 2006;43:35-41
20. Buchacz K, Baker RK, Palella FJ Jr, et al. : Disparities in prevalence of key chronic diseases by gender and race/ ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther 2013;18:65-75
21. McCormick CL, Francis AM, Iliffe K, et al. : Increasing obesity in treated female HIV patients from Sub-Saharan Africa: Potential causes and possible targets for intervention. Front Immunol 2014;5:507
22. Hodgson LM, Ghattas H, Pritchitt H, et al. : Wasting and obesity in HIV outpatients. AIDS 2001;15:2341-2342
23. Lakey WC, Yang LY, Yancy W, et al. : From wasting to obesity: Initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses 2013; 29:435-440
24. Lloyd-Jones D, Adams RJ, Brown TM, et al. : Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010;121:e46-e215
25. Swinburn B, Sacks G, and Ravussin E: Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr 2009;90:1453-1456
26. Westerterp KR and Speakman JR: Physical activity energy expenditure has not declined since the 1980s and matches energy expenditures of wild mammals. Int J Obes (Lond) 2008;32:1256-1263
27. Craig CL, Russell SJ, Cameron C, and Bauman A:. Twenty-year trends in physical activity among Canadian adults. Can J Public Health 2004;95:59-63
28. Macallan DC, Noble C, Baldwin C, et al. : Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995;333:83-88
29. Powanda MC and Beisel WR: Metabolic effects of infection on protein and energy status. J Nutr 2003;133:322S-327S
30. Koethe JR, Bian A, Shintani AK, et al. : An association between adiposity and serum levels of macrophage inflammatory protein-1alpha and soluble CD14 in HIVinfected adults: Results from a cross-sectional study. Antivir Ther 2013;18:729-733
31. Brown TT, Tassiopoulos K, Bosch RJ, et al. : Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care 2010;33:2244-2249
32. Duprez DA, Neuhaus J, Kuller LH, et al. : Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012;7:e44454
33. Triant VA, Meigs JB, and Grinspoon SK: Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009;51:268-273
34. Kuller LH, Tracy R, Belloso W, et al. : Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008;5:e203
35. De Wit S, Sabin CA, Weber R, et al. : Incidence and risk factors for new-onset diabetes in HIV-infected patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008;31:1224-1229
36. Koethe J, Jenkins C, Turner M, et al. : Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy. HIV Med 2015;16:67-72
37. Boodram B, Plankey MW, Cox C, et al. : Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Womens Interagency HIV Study. AIDS Patient Care STDS 2009;23:1009-1016
38. Jones CY, Hogan JW, Snyder B, et al. : Overweight and human immunodeficiency virus (HIV) progression in women: Associations of HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 2003;37(Suppl 2): S69-80
39. Koethe JR, Hulgan T, and Niswender K: Adipose tissue and immune function: A review of evidence relevant to HIV infection. J Infect Dis 2013;208:1194-1201
40. Stanley TL and Grinspoon SK: Body composition and metabolic changes in HIV-infected patients. J Infect Dis 2012;205(Suppl 3):S383-390